Improving patient recruitment to multicentre clinical trials: The case for employing a data manager in a district general hospital-based oncology centre

Clinical Oncology

Volumn 13, Issue 1, 2001, Pages 38-43

  Street, A ^a   Strong, J ^b   Karp, S ^c  

^a UNIVERSITY OF YORK   (United Kingdom)

^b Pharmax Limited   (United Kingdom)

^c NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Clinical trials; Data manager; Oncology; Patient recruitment; Research and development funding

Indexed keywords

ARTICLE; CANCER CENTER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMPLOYMENT; EVALUATION; GENERAL HOSPITAL; HEALTH CARE COST; HUMAN; INFORMATION PROCESSING; MANAGER; MEDICAL RESEARCH; MEDICAL STAFF; MULTICENTER STUDY; PATIENT SELECTION; PRIORITY JOURNAL; PUBLIC HOSPITAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; RESPONSIBILITY; TEACHING HOSPITAL; UNITED KINGDOM; WORKLOAD;

EID: 0035116728     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.2001.9212     Document Type: Article

References (23)

1. Martin JF, Hendersen, WG, Zacharski LR. Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studies. Am J Oncol 1984;7:173-82.
2. De Vita VT. Breast cancer therapy: exercising all our options. N Engl J Med 1989;320:527-9.
3. Fisher B. On clinical trial participation. J Clin Oncol 1991;9:1927-30.
4. Friedman MA, Cain DF. National Cancer Institute sponsored cooperative clinical trials. Cancer 1990;65 (Suppl 10):2376-82.
5. Gotay CC. Accrual to cancer clinical trials: directions from the research literature. Soc Sci Med 1991;33:569-77.
6. Slevin M, Mossman J, Bowling A, et al. Volunteers or victims: patients' views of randomised clinical trials. Br J Cancer 1995;71:1270-4.
7. Taylor KM, Margolese RG, Soskolne CL. Physicians' reasons for not entering eligible patients in a randomised clinical trial of surgery for breast cancer. N Engl J Med 1984;310:1363-7.
8. Schain WS. Barriers to clinical trials: knowledge and attitudes of potential participants. Cancer 1994;74:2666-71.
9. Benson AB, Pregler JP, Bean JA, et al. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois cancer centre study. J Clin Oncol 1991;9:2067-75.
10. Taylor KM, Feldstein ML, Skeel RT, et al. Fundamental dilemmas of the randomised clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group Investigators. J Clin Oncol 1994;12:1796-805.
11. Mansour EG. Barriers to clinical trials: knowledge and attitudes of health care providers. Cancer 1994;74:2672-5.
12. Foley JF, Moertal CG. Improving accrual into cancer clinical trials. J Cancer Educ 1991;6:165-73.
13. Smyth JF, Mossman J, Hall R, et al. Conducting clinical research in the new NHS: the model of cancer. BMJ 1994;309:457-61.
14. Hancock BW, Aitken M, Radstone C, et al. Why don't cancer patients get entered into clinical trials? Experience of the Sheffield Lymphoma Group's Collaboration in British National Lymphoma Investigation studies. BMJ 1997;314:36-7.
15. NHS Executive. Extracontractual referrals: purchaser arrangements and provider tariffs for 1996/97. Warrington: North West Regional Office, 1997.
16. NHS Executive. Northern and Yorkshire ECR tariffs and contact points 1995/96. Durham: Northern and Yorkshire Regional Health Authority, 1996.
17. Horwich A, Sleijfer DT, Fossa SD, et al. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good prognosis metastatic nonseminomatous germ cell cancer: a multi-institutional Medical Research Council/European Organization for Research and Treatment of Cancer trial. J Clin Oncol 1997;15:1844-52.
18. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 1980;84:817-30.
19. Ramsey JB. Tests for specification errors in classical linear least squares regression analysis. J R Stat Soc [Series B] 1969;31:350-71.
20. Sprangers MA, Cull A, Bjordal K, et al. For the EORTC Study Group on Quality of Life. The European Organization for Research and Treatment of Cancer approach to quality of life assessment: guidelines for developing questionnaire modules. Quality Life Res 1993;2:287-95.
21. Drummond MF, Crump BJ, Little VA. Funding research and development in the NHS. Lancet 1992;339:230-1.
22. Culyer A. Supporting research and development in the NHS. London: HMSO, 1994.
23. NHS Executive. The new funding system for research and development in the NHS: an outline (Department of Health 96CC0011). London: NHS Executive, 1996.